Viridian Therapeutics
VRDN
VRDN
59 hedge funds and large institutions have $72.5M invested in Viridian Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.69M | |
| 2 | +$3.74M | |
| 3 | +$1.11M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$894K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$689K |
Top Sellers
| 1 | -$659K | |
| 2 | -$646K | |
| 3 | -$215K | |
| 4 |
Morgan Stanley
New York
|
-$184K |
| 5 |
Goldman Sachs
New York
|
-$132K |